(Q40586207)

21 September 2017

title

Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells (English)

1 reference

21 September 2017

Oekyung Kim

1

1 reference

21 September 2017

Tianyun Jiang

2

1 reference

21 September 2017

Yingqiu Xie

3

1 reference

21 September 2017

Zhiyong Guo

4

1 reference

21 September 2017

Hegang Chen

5

1 reference

21 September 2017

Yun Qiu

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

10

1 reference

21 September 2017

page(s)

1838-1844

1 reference

Relationship between serum levels of interleukin-6, tumor necrosis factor-alpha and bone turnover markers in prostate cancer patients

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Interferon-alpha inhibits proliferation of Ba/F3 cells by interfering with interleukin-3 action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Selective activation of small GTPase RhoA by tyrosine kinase Etk through its pleckstrin homology domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Interleukin-6 and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Interaction between tyrosine kinase Etk and a RUN domain- and FYVE domain-containing protein RUFY1. A possible role of ETK in regulation of vesicle trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

inferred from DOI database lookup

7 January 2021

based on heuristic

Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

inferred from DOI database lookup

7 January 2021

based on heuristic

Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207304

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1207304

1 reference

Dimensions Publication ID

21 September 2017

1042578413

0 references

1 reference